🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
1.730
+0.010 (0.58%)
At close: Nov 18, 2026, 4:00 PM EST
1.725
-0.005 (-0.29%)
After-hours: Nov 18, 2026, 5:22 PM EST

Grace Therapeutics Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
21.3116.9822.1323.0127.8830.34
Short-Term Investments
----0.0213.32
Cash & Short-Term Investments
21.3116.9822.1323.0127.8943.66
Cash Growth
26.38%-23.30%-3.79%-17.52%-36.12%-28.11%
Other Receivables
0.020.020.130.720.80.55
Receivables
0.020.020.130.720.80.55
Prepaid Expenses
0.630.380.450.280.60.72
Other Current Assets
-----0.35
Total Current Assets
21.9617.3822.7124.0129.2945.28
Property, Plant & Equipment
0.01000.010.570.57
Goodwill
8.148.148.148.148.1412.96
Other Intangible Assets
27.641.1441.1441.1541.1369.81
Total Assets
57.766.6571.9973.379.12128.62

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
1.610.70.61.011.241.68
Accrued Expenses
-1.441.330.682.091.48
Current Portion of Leases
----0.080.1
Total Current Liabilities
1.612.151.931.683.413.26
Long-Term Leases
----0.410.19
Long-Term Deferred Tax Liabilities
0.60.612.315.517.3516.89
Other Long-Term Liabilities
--1.144.36-0.01
Total Liabilities
2.222.765.3811.5611.1720.35

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
0000258.29257.99
Additional Paid-In Capital
307.92298.41293.33278.913.9712.15
Retained Earnings
-246.4-228.48-220.69-211.12-198.27-155.84
Comprehensive Income & Other
-6.04-6.04-6.04-6.04-6.04-6.04
Shareholders' Equity
55.4863.966.6161.7467.96108.27
Total Liabilities & Equity
57.766.6571.9973.379.12128.62

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
----0.490.3
Net Cash (Debt)
21.3116.9822.1323.0127.4143.37
Net Cash Growth
26.38%-23.30%-3.79%-16.05%-36.80%-28.49%
Net Cash Per Share
1.191.031.832.413.697.06
Filing Date Shares Outstanding
21.0416.2713.839.47.447.38
Total Common Shares Outstanding
21.0416.0213.729.47.447.38
Working Capital
20.3515.2320.7822.3325.8842.02
Book Value Per Share
2.643.994.866.579.1414.67
Tangible Book Value
19.7514.6217.3312.4618.6925.5
Tangible Book Value Per Share
0.940.911.261.332.513.45
Machinery
-00.010.610.670.7
SEC Filings: 10-K · 10-Q